Supernova

This study is testing the effectiveness of a new drug to prevent COVID-19.

It is being carried out in Greater Manchester by a team of researchers at Manchester University NHS Foundation Trust.

• aged 18-55
• No COVID-19 infection in the past 6 months
• No COVID-19 vaccination in the past 3 months
• No history of cancer/malignancy within the past 5 years

• Manchester Royal Infirmary (part of Manchester University NHS Foundation Trust)

Taking part will involve:

• Attending 11 clinic visits over a 12-month period
• The study drug will be given at one visit via intramuscular injection*
• Visits will include a range of tests (eg blood samples, heart and blood pressure checks) as well as questions about lifestyle and medical history

Participants will receive a payment of £50 for each onsite visit, plus reasonable travel expenses.

* Participants will be randomly selected to receive either the study drug or a placebo.

Contact Us